Global Remdesivir Market – Industry Trends and Forecast to 2028

Market Analysis and Insights of Remdesivir Market

Remdesivir market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market to account to USD 9,925.61 million by 2028 and will grow at a CAGR of 27.46% in the above mentioned forecast period.

The remdesivir market is majorly driven by the rapidly increasing need for a drug that can be used for the treatment of patient with severe COVID-19 symptoms. In addition, the high occurrences of pandemics like COVID-19, Ebola, along with the increasing prevalence of viral diseases are also contributing to rising in the global market. Also the Remdesivir (RDV) is one of the promising drugs which are currently being used for the treatment of the COVID19 disease and is the key factor affecting remdesivir market trends over the forecast period of 2021 to 2028. Additionally, the rising focus on making remdesivir both available and affordable to governments and patients around the globe is also responsible for the development of remdesivir market over the forecast period. Furthermore, the remdesivir is being tested in multiple phase 3 clinical trials as a treatment for reasonably and severely ill COVID-19 patients and is also exceedingly influencing the demand and growth of the remdesivir market.

Likewise, the drug manufacturer is increasing its remdesivir production owing to the high demand for this drug which is raising the remdesivir market growth. While, the limited knowledge about the safety and efficiency regarding using remdesivir to treat patients with COVID-19 at hospital and high cost of remdesivir is expected to obstruct the growth of the remdesivir market in the above mentioned forecast period. Additionally, the high R&D investment is also lifting the growth of the remdesivir market.

The high investment in research and development to examine for the further uses of remdesivir and will further accelerate the expansion of the remdesivir market and are also are offering significant growth opportunities for the market in the forecast period of 2021 to 2028.  

This remdesivir market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on remdesivir market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Remdesivir Market Scope and Market Size

Remdesivir market is segmented on the basis of dosage, patient type, form, application and end users. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of dosage, the remdesivir market is segmented into 2.5mg, 5mg, 100mg and 200mg.
• Based on patient type, the remdesivir market is segmented into adult, pediatric and geriatric.
• On the basis of form, the remdesivir market is segmented into lyophilized powder and concentrated solution.
• Based on application, the remdesivir market is segmented into ebola, SARS-COV, MERS-COV and COVID-19. COVID-19 has further been segmented into invasive mechanical ventilation and non-Invasive mechanical ventilation.
• The end users segment of the remdesivir market is segmented into hospitals, clinics, pharmacy and drug stores and online pharmacies.

Remdesivir Market Country Level Analysis

Remdesivir market is analyzed and market size insights and trends are provided by country, dosage, patient type, form, application and end users as referenced above.

The countries covered in the remdesivir market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa(MEA), Brazil, Argentina and Rest of South America as part of South America.

North America region leads the remdesivir market owing to the rapidly rising cases of covid-19, high prevalence of diseases, easy availability, and strong presence of leading market players in this region. Asia-Pacific is expected to expand at a significant growth rate over the forecast period of 2021 to 2028 owing to the high frequencies of viral disease outburst and conceding of authorization to manufacture remdesivir by the parent company within this region. 

The country section of the remdesivir market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

Remdesivir market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for remdesivir market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the remdesivir market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Remdesivir Market Share Analysis

Remdesivir market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to remdesivir market.

The major players covered in the remdesivir market report are Gilead Sciences, Inc., BrightGene Bio-Medical Technology Co., Ltd., Saptagir Laboratories Pvt. Ltd., Ferozsons Laboratories Limited, Mylan N.V., Hovione, Syngene, EVA PHARM, Zydus Cadila., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Biocon, Hikma Pharmaceuticals PLC, Beximco Pharmaceuticals Ltd., Hunan Warrant Chiral Pharmaceutical Co., Ltd., Hetero, Everest Organics Limited, PI & PI BOITECH INC, Cipla Inc., and Jubilant Life Sciences Limited among other domestic and global players. Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-58721